- Home
- YMM vs PCVX Comparison
YMM vs PCVX Comparison
Compare YMM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- PCVX
- Stock Information
- Founded
- YMM 2011
- PCVX 2013
- Country
- YMM China
- PCVX United States
- Employees
- YMM N/A
- PCVX N/A
- Industry
- YMM Computer Software: Prepackaged Software
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- YMM Technology
- PCVX Health Care
- Exchange
- YMM Nasdaq
- PCVX Nasdaq
- Market Cap
- YMM 11.8B
- PCVX 9.6B
- IPO Year
- YMM 2021
- PCVX 2020
- Fundamental
- Price
- YMM $10.07
- PCVX $30.65
- Analyst Decision
- YMM Buy
- PCVX Strong Buy
- Analyst Count
- YMM 3
- PCVX 9
- Target Price
- YMM $12.67
- PCVX $136.50
- AVG Volume (30 Days)
- YMM 12.7M
- PCVX 3.7M
- Earning Date
- YMM 05-20-2025
- PCVX 05-07-2025
- Dividend Yield
- YMM 0.81%
- PCVX N/A
- EPS Growth
- YMM 47.43
- PCVX N/A
- EPS
- YMM 0.40
- PCVX N/A
- Revenue
- YMM $1,539,729,280.00
- PCVX N/A
- Revenue This Year
- YMM N/A
- PCVX N/A
- Revenue Next Year
- YMM $15.01
- PCVX N/A
- P/E Ratio
- YMM $25.02
- PCVX N/A
- Revenue Growth
- YMM 33.22
- PCVX N/A
- 52 Week Low
- YMM $6.66
- PCVX $27.66
- 52 Week High
- YMM $13.85
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- YMM 33.79
- PCVX 26.64
- Support Level
- YMM $9.85
- PCVX $28.58
- Resistance Level
- YMM $10.43
- PCVX $32.72
- Average True Range (ATR)
- YMM 0.60
- PCVX 3.75
- MACD
- YMM -0.20
- PCVX 0.12
- Stochastic Oscillator
- YMM 16.89
- PCVX 29.09
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.